3D-Printed Melatonin Tablets with Braille Motifs for the Visually Impaired
Pharmaceuticals · 01.08.2024 · 17 (8) · 1017
DOI: 10.3390/ph17081017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 01.08.2024. Verfasst von Chrystalla Protopapa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pharmaceutical Technology, Department of Pharmacy, National and Kapodistrian University of Athens, 15784 Athens, Greece. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Hellenic Foundation for Research and Innovation (HFRI).
Abstract (Originalsprache)
An innovative approach for creating customized dosage forms and supporting patient populations with specific requirements who need additional support to improve drug adherence is 3D printing. This work introduces liquid crystal display (LCD) 3D printing as a means of developing melatonin (MLT) tablets. For patients who are blind or visually challenged, Braille patterns were displayed on the tablet surface in addition to the optimization of printing hydrogel inks. Owing to the great printing accuracy, blind patients could validate the Braille patterns that provided the required information. Upon further examination MLT was found to be present in the photopolymerized resins in an amorphous state. The choice of poly(ethylene glycol)-diacrylate (PEGDA) with varying molecular weights and the inclusion of surfactants or solubilizers interfered with the photopolymerization of the resin, hence controlling the rates of MLT dissolution towards the sought sustained release. Nuclear magnetic resonance (NMR) analysis showed that photopolymerization of the PEGDA resins in the printed dosage forms has taken place. A small batch scale-up investigation showed that LCDs could print a significant number of tablets quickly—about twenty-four minutes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Pharmaceutical Technology, Department of Pharmacy, National and Kapodistrian University of Athens, 15784 Athens, Greece.
- Section of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, 15784 Athens, Greece.
- Centre for Research Innovation, University of Greenwich, Medway Campus, Chatham ME4 4TB, UK.
- School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
- Delta Pharmaceutics Ltd., 1-3 Manor Road, Chatham ME4 6AE, UK.
ORCID-Profile: Chrystalla Protopapa, Angeliki Siamidi, Siva Kolipaka, Laura Andrade Junqueira, Dennis Douroumis, Marilena Vlachou
Förderung
- the Hellenic Foundation for Research and Innovation (HFRI)
Zitieren
APA
Protopapa, C., Siamidi, A., Sakellaropoulou, A., Kolipaka, S., Junqueira, L. A., Tabriz, A. G., Douroumis, D., & Vlachou, M. (2024). 3D-Printed Melatonin Tablets with Braille Motifs for the Visually Impaired. Pharmaceuticals, 17(8), 1017. https://doi.org/10.3390/ph17081017
Vancouver
Protopapa C, Siamidi A, Sakellaropoulou A, Kolipaka S, Junqueira LA, Tabriz AG, et al. 3D-Printed Melatonin Tablets with Braille Motifs for the Visually Impaired. Pharmaceuticals. 2024;17(8):1017. doi:10.3390/ph17081017
BibTeX
@article{Protopapa2024,
author = {Protopapa, Chrystalla and Siamidi, Angeliki and Sakellaropoulou, Aikaterini and Kolipaka, Siva and Junqueira, Laura Andrade and Tabriz, Atabak Ghanizadeh and Douroumis, Dennis and Vlachou, Marilena},
title = {3D-Printed Melatonin Tablets with Braille Motifs for the Visually Impaired},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {8},
pages = {1017},
doi = {10.3390/ph17081017}
}
EUVIMED